Cargando…

AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)

Tumor Treating Fields (TTFields), an approved treatment modality for glioblastoma, are delivered via non-invasive application of low-intensity, intermediate-frequency, alternating electric fields. TTFields application leads to abnormal mitosis, aneuploidy, and increased cell granularity, which are o...

Descripción completa

Detalles Bibliográficos
Autores principales: Shteingauz, Anna, Porat, Yaara, Voloshin, Tali, Schneiderman, Rosa S., Munster, Mijal, Zeevi, Einav, Kaynan, Noa, Gotlib, Karnit, Giladi, Moshe, Kirson, Eilon D., Weinberg, Uri, Kinzel, Adrian, Palti, Yoram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195570/
https://www.ncbi.nlm.nih.gov/pubmed/30341282
http://dx.doi.org/10.1038/s41419-018-1085-9
_version_ 1783364412696952832
author Shteingauz, Anna
Porat, Yaara
Voloshin, Tali
Schneiderman, Rosa S.
Munster, Mijal
Zeevi, Einav
Kaynan, Noa
Gotlib, Karnit
Giladi, Moshe
Kirson, Eilon D.
Weinberg, Uri
Kinzel, Adrian
Palti, Yoram
author_facet Shteingauz, Anna
Porat, Yaara
Voloshin, Tali
Schneiderman, Rosa S.
Munster, Mijal
Zeevi, Einav
Kaynan, Noa
Gotlib, Karnit
Giladi, Moshe
Kirson, Eilon D.
Weinberg, Uri
Kinzel, Adrian
Palti, Yoram
author_sort Shteingauz, Anna
collection PubMed
description Tumor Treating Fields (TTFields), an approved treatment modality for glioblastoma, are delivered via non-invasive application of low-intensity, intermediate-frequency, alternating electric fields. TTFields application leads to abnormal mitosis, aneuploidy, and increased cell granularity, which are often associated with enhancement of autophagy. In this work, we evaluated whether TTFields effected the regulation of autophagy in glioma cells. We found that autophagy is upregulated in glioma cells treated with TTFields as demonstrated by immunoblot analysis of the lipidated microtubule-associated protein light chain 3 (LC3-II). Fluorescence and transmission electron microscopy demonstrated the presence of LC3 puncta and typical autophagosome-like structures in TTFields-treated cells. Utilizing time-lapse microscopy, we found that the significant increase in the formation of LC3 puncta was specific to cells that divided during TTFields application. Evaluation of selected cell stress parameters revealed an increase in the expression of the endoplasmic reticulum (ER) stress marker GRP78 and decreased intracellular ATP levels, both of which are indicative of increased proteotoxic stress. Pathway analysis demonstrated that TTFields-induced upregulation of autophagy is dependent on AMP-activated protein kinase (AMPK) activation. Depletion of AMPK or autophagy-related protein 7 (ATG7) inhibited the upregulation of autophagy in response to TTFields, as well as sensitized cells to the treatment, suggesting that cancer cells utilize autophagy as a resistance mechanism to TTFields. Combining TTFields with the autophagy inhibitor chloroquine (CQ) resulted in a significant dose-dependent reduction in cell growth compared with either TTFields or CQ alone. These results suggest that dividing cells upregulate autophagy in response to aneuploidy and ER stress induced by TTFields, and that AMPK serves as a key regulator of this process.
format Online
Article
Text
id pubmed-6195570
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-61955702018-10-22 AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields) Shteingauz, Anna Porat, Yaara Voloshin, Tali Schneiderman, Rosa S. Munster, Mijal Zeevi, Einav Kaynan, Noa Gotlib, Karnit Giladi, Moshe Kirson, Eilon D. Weinberg, Uri Kinzel, Adrian Palti, Yoram Cell Death Dis Article Tumor Treating Fields (TTFields), an approved treatment modality for glioblastoma, are delivered via non-invasive application of low-intensity, intermediate-frequency, alternating electric fields. TTFields application leads to abnormal mitosis, aneuploidy, and increased cell granularity, which are often associated with enhancement of autophagy. In this work, we evaluated whether TTFields effected the regulation of autophagy in glioma cells. We found that autophagy is upregulated in glioma cells treated with TTFields as demonstrated by immunoblot analysis of the lipidated microtubule-associated protein light chain 3 (LC3-II). Fluorescence and transmission electron microscopy demonstrated the presence of LC3 puncta and typical autophagosome-like structures in TTFields-treated cells. Utilizing time-lapse microscopy, we found that the significant increase in the formation of LC3 puncta was specific to cells that divided during TTFields application. Evaluation of selected cell stress parameters revealed an increase in the expression of the endoplasmic reticulum (ER) stress marker GRP78 and decreased intracellular ATP levels, both of which are indicative of increased proteotoxic stress. Pathway analysis demonstrated that TTFields-induced upregulation of autophagy is dependent on AMP-activated protein kinase (AMPK) activation. Depletion of AMPK or autophagy-related protein 7 (ATG7) inhibited the upregulation of autophagy in response to TTFields, as well as sensitized cells to the treatment, suggesting that cancer cells utilize autophagy as a resistance mechanism to TTFields. Combining TTFields with the autophagy inhibitor chloroquine (CQ) resulted in a significant dose-dependent reduction in cell growth compared with either TTFields or CQ alone. These results suggest that dividing cells upregulate autophagy in response to aneuploidy and ER stress induced by TTFields, and that AMPK serves as a key regulator of this process. Nature Publishing Group UK 2018-10-19 /pmc/articles/PMC6195570/ /pubmed/30341282 http://dx.doi.org/10.1038/s41419-018-1085-9 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Shteingauz, Anna
Porat, Yaara
Voloshin, Tali
Schneiderman, Rosa S.
Munster, Mijal
Zeevi, Einav
Kaynan, Noa
Gotlib, Karnit
Giladi, Moshe
Kirson, Eilon D.
Weinberg, Uri
Kinzel, Adrian
Palti, Yoram
AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)
title AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)
title_full AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)
title_fullStr AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)
title_full_unstemmed AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)
title_short AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)
title_sort ampk-dependent autophagy upregulation serves as a survival mechanism in response to tumor treating fields (ttfields)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195570/
https://www.ncbi.nlm.nih.gov/pubmed/30341282
http://dx.doi.org/10.1038/s41419-018-1085-9
work_keys_str_mv AT shteingauzanna ampkdependentautophagyupregulationservesasasurvivalmechanisminresponsetotumortreatingfieldsttfields
AT poratyaara ampkdependentautophagyupregulationservesasasurvivalmechanisminresponsetotumortreatingfieldsttfields
AT voloshintali ampkdependentautophagyupregulationservesasasurvivalmechanisminresponsetotumortreatingfieldsttfields
AT schneidermanrosas ampkdependentautophagyupregulationservesasasurvivalmechanisminresponsetotumortreatingfieldsttfields
AT munstermijal ampkdependentautophagyupregulationservesasasurvivalmechanisminresponsetotumortreatingfieldsttfields
AT zeevieinav ampkdependentautophagyupregulationservesasasurvivalmechanisminresponsetotumortreatingfieldsttfields
AT kaynannoa ampkdependentautophagyupregulationservesasasurvivalmechanisminresponsetotumortreatingfieldsttfields
AT gotlibkarnit ampkdependentautophagyupregulationservesasasurvivalmechanisminresponsetotumortreatingfieldsttfields
AT giladimoshe ampkdependentautophagyupregulationservesasasurvivalmechanisminresponsetotumortreatingfieldsttfields
AT kirsoneilond ampkdependentautophagyupregulationservesasasurvivalmechanisminresponsetotumortreatingfieldsttfields
AT weinberguri ampkdependentautophagyupregulationservesasasurvivalmechanisminresponsetotumortreatingfieldsttfields
AT kinzeladrian ampkdependentautophagyupregulationservesasasurvivalmechanisminresponsetotumortreatingfieldsttfields
AT paltiyoram ampkdependentautophagyupregulationservesasasurvivalmechanisminresponsetotumortreatingfieldsttfields